While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

Share on Pinterest Ozempic, the active ingredient of which is semaglutide, can also reduce the risk of heart disease, according to research. Steve Christo – Corbis/Corbis via Getty Images ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

As research continues, the role of semaglutide in cardiovascular care will likely expand, potentially transforming how we approach heart disease prevention in at-risk populations. With heart ...

Semaglutide can rapidly reduce heart attacks and other serious ... all SELECT patients had a history of heart disease, placing them at high risk. It is worth noting, they say, given their ...

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

Landmark' data has revealed a popular weight loss medicine slashes the risk of heart attack, stroke or heart disease death ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

In people with diabetes, Farxiga drops A1C levels by roughly 0.6%, which is not a huge amount compared to other diabetes ...